Latest News

Friday October 23, 2020

We welcome our new ASI Sustaining Member: GenScript


Our ASI Sustaining Members recognise the importance of supporting ASI and Immunology researchers in Australia and New Zealand. 

We are grateful and proud to introduce our newest ASI Sustaining Member: GenScript.

About GenScript

Genscript is the world’s leading biotech company providing life sciences services and products.
With gene synthesis, oligo, CRISPR, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services that can be your one-stop solutions for your works. 
GenScript pioneered in gene synthesis technology with over 600,000 completed gene synthesis projects for scientists around the world. As an award-winning custom antibody supplier with over 8,000 monoclonal and 40,000 polyclonal antibodies generated to date, GenScript offers a comprehensive antibody production and service portfolio. From gene to protein, from bench work to mass production, our expert scientists and talented technical support team have got you covered all the way 24-hour!
As of June 2020, more than 51,000 peer-reviewed journal articles cited GenScript’s services and products, making GenScript the most frequently cited Biotechnology Company in the world.

Back to All Blogs

© ASI 2021

ABN 76 330 189 856 | ARBN 084 971 559 | CAV A0016266B